Details for New Drug Application (NDA): 218993
✉ Email this page to a colleague
NDA 218993 describes MIDAZOLAM IN 0.9% SODIUM CHLORIDE, which is a drug marketed by Gland Pharma Ltd, Hikma, and Inforlife, and is included in three NDAs. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the MIDAZOLAM IN 0.9% SODIUM CHLORIDE profile page.
The generic ingredient in MIDAZOLAM IN 0.9% SODIUM CHLORIDE is midazolam. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the midazolam profile page.
The generic ingredient in MIDAZOLAM IN 0.9% SODIUM CHLORIDE is midazolam. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the midazolam profile page.
Summary for 218993
| Tradename: | MIDAZOLAM IN 0.9% SODIUM CHLORIDE |
| Applicant: | Gland Pharma Ltd |
| Ingredient: | midazolam |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218993
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | midazolam | SOLUTION;INTRAVENOUS | 218993 | ANDA | Gland Pharma Limited | 68083-618 | 68083-618-10 | 10 POUCH in 1 CARTON (68083-618-10) / 1 BAG in 1 POUCH / 50 mL in 1 BAG |
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | midazolam | SOLUTION;INTRAVENOUS | 218993 | ANDA | Gland Pharma Limited | 68083-619 | 68083-619-10 | 10 POUCH in 1 CARTON (68083-619-10) / 1 BAG in 1 POUCH / 100 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/50ML (1MG/ML) | ||||
| Approval Date: | Aug 12, 2024 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/100ML (1MG/ML) | ||||
| Approval Date: | Aug 12, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
